Robert Davey, PhD
Boston University Chobanian & Avedisian School of Medicine
Dept of Microbiology

PhD, University of Adelaide

Dr. Robert Davey, PhD is a currently a Professor of Microbiology at the Boston University School of Medicine. Dr. Davey received his doctorate in Microbiology and Immunology at the University of Adelaide in Australia. He continued his training as a Postdoctoral Fellow at the Howard Hughes Medical Institute and then at the Division of Hematology, both with Dr. James Cunningham at Brigham and Women's Hospital and Harvard Medical School.

Dr. Davey's first academic appointment was as an Instructor in Medicine at Harvard. He then held an Assistant Professor position which he got promoted to Adjunct Associate Professor at the Department of Microbiology and Immunology at the University of Texas Medical Branch.

Dr. Davey was also a Ewing Halsell Scholar and Scientist at the Department of Virology and Immunology at the Texas Biomedical Research Institute. As a Scientist at the Texas Biomedical Research Institute, Dr. Davey's work was focused on identification of cellular factors important for establishing infection by filovirus and bunyaviruses. His work has culminated in a deeper understanding of the entry and cell signaling pathways that are used by these viruses to penetrate the cell membrane and establish infection. His work with Ebolavirus has been published in the high-impact journals PLoS Pathogens, PNAS and a new article on host factor dependence in Science that was featured on the cover page. Dr. Davey’s group works collaboratively with a number of groups providing sophisticated molecular biology and cell biology techniques for the study of pathogenic viruses including Ebolavirus for which the lab mainly works. He has developed high throughput screening techniques for Ebolavirus. He also performs contract work testing drugs and compounds for ebolavirus infection inhibition. His team is well trained in ABSL4 procedures and have been working with Ebolavirus since 2006.

From 2015-2017, Dr. Davey held the role of Interim Chair in the Department of Virology and Immunology at the Texas Biomedical Research Institute. He is also Director of ABSL4 at the Texas Biomedical Research Institute.

Boston University
National Emerging Infectious Disease Lab

Boston University Chobanian & Avedisian School of Medicine
Evans Center for Interdisciplinary Biomedical Research

Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

Assay development and execution of live virus testing in support of the Harvard-AbbVie Research Collaboration
03/01/2021 - 02/28/2024 (Subcontract PI)
President & Fellows of Harvard College on behalf of Harvard Medical School AbbVie

Antiviral Lead Identification to Treat Filovirus Infections
08/12/2019 - 07/31/2023 (Subcontract PI)
Purdue University NIH NIAID

Small molecule inhibitors of Ebola virus polymerase function
02/01/2022 - 01/31/2023 (Subcontract PI)
Icahn School of Medicine at Mount Sinai NIH NIAID

4-(Aminomethyl)benzamides as Novel Anti-Ebola Agents
08/16/2019 - 07/31/2022 (Subcontract PI)
Chicago BioSolutions, Inc. NIH NIAID

Modeling Filovirus Infection of and Trafficking through Skin
08/01/2018 - 07/31/2022 (Subcontract PI)
The University of Iowa NIH NIAID
5 R01 AI134733-04

Evaluation of SARS-COV-2 nuclease conjugates for treatment in the rodent model of SARS-COV-2 disease
07/01/2021 - 06/30/2022 (PI)
Massachusetts Institute of Technology

Testing of brequinar in combination with dipyridamole for ClearCreekBio
06/15/2021 - 06/30/2022 (PI)
Clear Creek Bio, Inc.

Neutralization and binding of antibody to virus by Regeneron antibodies
07/08/2020 - 06/30/2022 (Subcontract PI)
Regeneron Pharmaceuticals, Inc. HHS ASPR BARDA

Structural and Functional Characterization of the Ebola Virus Replication Complex (Core C)
07/01/2019 - 06/30/2022 (Subcontract PI)
The Washington University NIH NIAID

Structural and Functional Characterization of the Ebola Virus Replication Complex
07/01/2018 - 06/30/2022 (Subcontract PI)
The Washington University NIH NIAID

Showing 10 of 15 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Mishra N, Teyra J, Boytz R, Miersch S, Merritt TN, Cardarelli L, Gorelik M, Mihalic F, Jemth P, Davey RA, Sidhu SS, Leung DW, Amarasinghe GK. Monoclonal antibodies binding data for SARS-CoV-2 proteins. Data Brief. 2022 Aug; 43:108415. PMID: 35789908; PMCID: PMC9232259; DOI: 10.1016/j.dib.2022.108415;
  2. Gourronc FA, Rebagliati MR, Kramer-Riesberg B, Fleck AM, Patten JJ, Geohegan-Barek K, Messingham KN, Davey RA, Maury W, Klingelhutz AJ. Adipocytes are susceptible to Ebola Virus infection. Virology. 2022 Aug; 573:12-22. PMID: 35690007
  3. Mishra N, Teyra J, Boytz R, Miersch S, Merritt TN, Cardarelli L, Gorelik M, Mihalic F, Jemth P, Davey RA, Sidhu SS, Leung DW, Amarasinghe GK. Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins. J Mol Biol. 2022 May 30; 434(10):167583. PMID: 35405107; PMCID: PMC8993412; DOI: 10.1016/j.jmb.2022.167583;
  4. Plescia CB, Lindstrom AR, Quintero MV, Keiser P, Anantpadma M, Davey R, Stahelin RV, Davisson VJ. Evaluation of Phenol-Substituted Diphyllin Derivatives as Selective Antagonists for Ebola Virus Entry. ACS Infect Dis. 2022 May 13; 8(5):942-957. PMID: 35357134; PMCID: PMC9112336; DOI: 10.1021/acsinfecdis.1c00474;
  5. El-Sayed NS, Jureka AS, Edwards MR, Lohan S, Williams CG, Keiser PT, Davey RA, Totonchy J, Tiwari RK, Basler CF, Parang K. Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus. Eur J Med Chem. 2021 Dec 15; 226:113862. PMID: 34583312; PMCID: PMC8454092; DOI: 10.1016/j.ejmech.2021.113862;
  6. Lennemann NJ, Dillard J, Ruggio N, Cooney AL, Schaack GA, Davey RA, Maury W. A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner. J Virol. 2021 08 25; 95(18):e0107321. PMID: 34232742; PMCID: PMC8387054; DOI: 10.1128/JVI.01073-21;
  7. Batra J, Mori H, Small GI, Anantpadma M, Shtanko O, Mishra N, Zhang M, Liu D, Williams CG, Biedenkopf N, Becker S, Gross ML, Leung DW, Davey RA, Amarasinghe GK, Krogan NJ, Basler CF. Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection. EMBO J. 2021 09 15; 40(18):e105658. PMID: 34260076; PMCID: PMC8441301; DOI: 10.15252/embj.2020105658;
  8. Morselli Gysi D, do Valle Í, Zitnik M, Ameli A, Gan X, Varol O, Ghiassian SD, Patten JJ, Davey RA, Loscalzo J, Barabási AL. Network medicine framework for identifying drug-repurposing opportunities for COVID-19. Proc Natl Acad Sci U S A. 2021 05 11; 118(19). PMID: 33906951; PMCID: PMC8126852; DOI: 10.1073/pnas.2025581118;
  9. Mena EL, Donahue CJ, Vaites LP, Li J, Rona G, O'Leary C, Lignitto L, Miwatani-Minter B, Paulo JA, Dhabaria A, Ueberheide B, Gygi SP, Pagano M, Harper JW, Davey RA, Elledge SJ. ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021 04 27; 118(17). PMID: 33827988; PMCID: PMC8092598; DOI: 10.1073/pnas.2023157118;
  10. Patten JJ, Keiser PT, Gysi D, Menichetti G, Mori H, Donahue CJ, Gan X, Do Valle I, Geoghegan-Barek K, Anantpadma M, Berrigan JL, Jalloh S, Ayazika T, Wagner F, Zitnik M, Ayehunie S, Anderson D, Loscalzo J, Gummuluru S, Namchuk MN, Barabasi AL, Davey RA. Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors In Vitro and In Vivo. bioRxiv. 2021 Apr 22.View Related Profiles. PMID: 33907750; PMCID: PMC8077576; DOI: 10.1101/2021.04.20.440626;
Showing 10 of 107 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 107 publications over 26 distinct years, with a maximum of 11 publications in 2021


2015 San Antonio business journal: Outstanding medical researcher, Healthcare heroes awards
2005 UTMB Graduate school teaching award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Junin virus
Lassa Fever
Contact for Mentoring:

620 Albany Street
Boston MA 02118
Google Map

Davey's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department